Skip to main content
Fig. 4 | Breast Cancer Research

Fig. 4

From: Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis

Fig. 4

Kaplan–Meier plots for the impact on overall survival (OS) of ESR1 and PIK3CA mutations. The detection of ESR1 or PIK3CA mutations had a significantly unfavorable impact on OS, however, no differential impact was observed across ESR1 or PIK3CA codon variants (A, B). Similarly, no differential prognostic impact was observed between number of concomitant ESR1 or PIK3CA alterations in the overall population (C, D) and according to previous CDK4/6i exposure (E–H). CNVs, Copy Number Variations; SNVs, Single Nucleotide Variations

Back to article page